Internal Medicine, Endocrinology, Diabetes, & Metabolism · Tulsa, OK
NPI
1235579202
Since 2013
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
9228 S Mingo Rd Ste 200
Tulsa, OK, 74133
Phone (918) 592-0999
Groups this clinician bills Medicare through
Medicare paid, 2024
$261K
7,666 services
Medicare patients, 2024
980
Average age 72
Drug cost, 2024
$4.0M
7,674 prescriptions
Company payments, 2025
$2,046
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elie Abed was code J0897 (injection, denosumab, 1 mg), 5,400 times for 67 patients. In total Elie Abed billed 7,666 services in 17 codes, and Medicare paid $261K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 5,400 | 67 | $20.50 | $111K |
| 99214 Office E&M - Established | Office | 1,112 | 637 | $83.13 | $92K |
| 95251 Test - Miscellaneous | Office | 404 | 217 | $24.06 | $9,721 |
| 99204 Office E&M - New | Office | 223 | 223 | $112.59 | $25K |
| 99213 Office E&M - Established | Office | 151 | 139 | $58.72 | $8,866 |
| 83036 Blood Count | Office | 107 | 92 | $8.91 | $953 |
| 96372 Injection Administration | Office | 92 | 69 | $10.55 | $970 |
| 76536 Ultrasound - Nonspecific | Office | 77 | 76 | $71.56 | $5,510 |
| 99203 Office E&M - New | Office | 42 | 42 | $77.93 | $3,273 |
| 10005 Other Organ Systems | Office | 29 | 29 | $96.66 | $2,803 |
| 36415 Venipuncture Blood Collection | Office | 15 | 11 | $6.86 | $103 |
By year: 2022 $223K for 6,308 services; 2023 $284K for 8,504 services; 2024 $261K for 7,666 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 107 | 92 | $8.91 | $953 |
| 36415 Venipuncture Blood Collection | 15 | 11 | $6.86 | $103 |
Medicare prescription drug claims, 2024
In 2024, the drug Elie Abed prescribed most often to Medicare patients was Levothyroxine Sodium, with 764 prescriptions and refills. In total Elie Abed wrote 7,674 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 764 | 1,992 | 236 | $6,515 |
| Ozempic Semaglutide | 551 | 832 | 143 | $785K |
| Mounjaro Tirzepatide | 462 | 549 | 121 | $585K |
| Synthroid Levothyroxine Sodium | 240 | 544 | 66 | $19K |
| Trulicity Dulaglutide | 228 | 329 | 69 | $324K |
| Metformin Hcl Er Metformin Hcl | 227 | 612 | 80 | $1,556 |
| Rosuvastatin Calcium Generic | 218 | 604 | 76 | $2,950 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 208 | 391 | 83 | $34K |
| Farxiga Dapagliflozin Propanediol | 182 | 352 | 42 | $193K |
| Methimazole Generic | 175 | 337 | 56 | $1,397 |
| Tresiba Flextouch U-200 Insulin Degludec | 174 | 337 | 55 | $192K |
| Jardiance Empagliflozin | 166 | 329 | 55 | $185K |
| Pioglitazone Hcl Generic | 160 | 446 | 58 | $1,965 |
| Atorvastatin Calcium Generic | 159 | 465 | 53 | $2,120 |
| Novolog Flexpen Insulin Aspart | 148 | 292 | 73 | $46K |
Brand drugs: 4,320 claims; generic drugs: 3,070 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elie Abed $2,046 ($2,046 in general payments such as food, travel and fees) from 25 companies. The largest payer was Abbott Laboratories with $281.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 17 | $281 |
| Amneal Pharmaceuticals LLC AMRX | 10 | $220 |
| Amgen Inc. AMGN | 15 | $207 |
| Novo Nordisk Inc NVO | 12 | $177 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $150 |
| Lilly USA, LLC LLY | 9 | $119 |
| Abbvie Inc. ABBV | 6 | $103 |
| Recordati_rare_diseases_inc. | 4 | $99.4 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $86.78 |
| Beta Bionics, Inc. BBNX | 3 | $69.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.